1st Constitution Bancorp Announces Second Quarter Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
1st Constitution Bancorp Announces Second Quarter Results

CRANBURY, N.J., July 24, 2014 (GLOBE NEWSWIRE) -- 1 ST Constitution Bancorp (Nasdaq: FCCY ), the holding company (the "Company") for 1 ST Constitution Bank, today reported a net loss of $440,000 or $0.06 per diluted share and net income of $202,000 or $0.03 per diluted share for the three and six month periods ended June 30, 2014, respectively.

The results of operations were impacted by two previously reported events during the first and second quarters of 2014. In the first quarter, the Company completed the acquisition of Rumson Fair Haven Bank and Trust Company ("Rumson") and incurred $1.4 million of merger-related expenses that reduced earnings by $897,000, or $0.13 per diluted share. In the second quarter, a loan for approximately $3.7 million was fully charged–off and the provision for loan losses was increased by a similar amount due to an apparent fraud by the borrower and its principals. This additional provision reduced net income by $2.2 million, or $0.30 per diluted share, and resulted in a net loss for the second quarter of 2014. Net income, adjusted for the effect of these events (Adjusted Net Income), was $1.8 million and $3.4 million for the three and six month periods ended June 30, 2014, respectively. Earnings per diluted share, as adjusted, was $0.25 and $0.48 for the same periods. For the three and six month periods ended June 30, 2013 net income was $1.6 million, or $0.25 per diluted share, and $2.9 million, or $0.47 per diluted share, respectively. Adjusted net income and adjusted earnings per diluted share are non-GAAP measures. A reconciliation of these non-GAAP measures to the reported net income or loss and net income or loss per diluted share is included in this release.

Second Quarter Highlights

  • Net interest income was $8.4 million in the second quarter of 2014 compared to $6.9 million in the first quarter of 2014 and $6.1 million in the second quarter of 2013. The net interest margin for each of these periods was 3.89%, 3.56% and 3.42%, respectively.
  • Loans increased $104 million during the second quarter of 2014 with mortgage warehouse loans increasing $78 million and commercial and commercial real estate loans increasing a combined $27 million. The loan to asset ratio increased to 64.5% at June 30, 2014 compared to 50.3% at December 31, 2013.
  • The integration of the former Rumson operations was completed at the end of the first quarter of 2014 and customer retention has been as expected with loans of approximately $134 million and deposits of approximately $179 million at June 30, 2014.
  • Three senior commercial loan officers with significant experience in the Monmouth County and Central New Jersey markets were recently recruited to focus on expanding and increasing our client base in these regions.

Robert F. Mangano, President and Chief Executive Officer, stated "it is important to note that a substantial portion of the loan loss provision in the second quarter was the result of a single isolated incident of apparent fraud perpetrated by one borrower. We intend to vigorously pursue all reasonable avenues of recovery available to us. However, due to the complex nature of this apparent fraud and the ongoing investigation, an estimate of any recovery cannot be determined at this time."

"Despite the significant additional provision for loan losses, we made significant progress in the second quarter increasing our loan portfolio which, combined with the former Rumson loans, generated a significant increase in net interest income and drove an expansion of our net interest margin. We achieved full integration of the former Rumson operations in a short period of time, which we believe will position us for further growth and improved operating efficiency," said Mr. Mangano.

Discussion of Financial Results

Net interest income for the quarter ended June 30, 2014 totaled $8.4 million an increase of $1.5 million, or 21%, compared to $6.9 million earned in the first quarter of 2014 and an increase of $2.3 million, or 37%, compared to $6.1 million earned in the second quarter of 2013. The increase was due principally to the increase in loans and the higher yield earned on earning assets.

The provision for loan losses was $4.1 million in the second quarter of 2014 compared to $500,000 in the first quarter of 2014 and $237,000 in the second quarter of 2013. The current quarter's provision includes $3.7 million of additional provision directly related to the charge-off of the apparent loan fraud noted above.

Non-interest income was $1.3 million in the second quarter of 2014 and declined compared to $1.6 million earned in the first quarter of 2014 due to lower gains from the sale of SBA loans. It also declined compared to $1.4 million earned in the second quarter of 2013 due to lower gains from the sale of residential mortgages.

Non-interest expenses were $6.7 million for the quarter ended June 30, 2014 compared to $7.3 million in the first quarter of this year and $5.2 million in the second quarter of 2013. Non-interest expenses in the first quarter of 2014 included $1.4 million of merger related expenses. The former operations of Rumson were included for the entire second quarter and contributed approximately $658,000 of expenses, compared to $396,000 of expenses (excluding merger related expenses) from the February 7, 2014 date of merger through the end of the first quarter.

At June 30, 2014, the allowance for loan losses was $7.4 million, an increase of $380,000 from December 31, 2013. As a percent of total loans, the allowance was 1.17% at the end of the second quarter of 2014 compared to 1.89% at year-end 2013. The decrease in the allowance as a percentage of total loans was primarily due to the Rumson acquisition accounting, which required the acquired loans to be recorded at their fair value and the elimination of Rumson's allowance for loan losses of $1.7 million at the date of merger. The fair value adjustment included a credit risk adjustment discount of $2.8 million, which was comprised of a non-accretive discount of $854,000 and an accretive general credit discount of $2.0 million. At June 30, 2014, the total credit risk adjustment was approximately $2.4 million and was comprised of the non-accretive credit discount of $854,000 and the general credit risk fair value discount of $1.5 million.

Total assets at June 30, 2014 increased to $986 million from $742 million at December 31, 2013 principally due to the acquisition of Rumson and an increase in short-term borrowings from the FHLB of New York, which partially funded the increase in loans during the six month period. Total portfolio loans at June 30, 2014 were $635 million, up $262 million from $373 million at December 31, 2013, and included $134 million of Rumson loans. During the second quarter of 2014, total portfolio loans increased $104 million, or by approximately 20%. Total investment securities at June 30, 2014 were $266 million compared to $252 million at December 31, 2013. Total deposits at June 30, 2014 were $820 million compared to $639 million at December 31, 2013 and increased principally due to the Rumson deposits of $179 million.

Regulatory capital ratios continue to reflect a strong capital position. The Company's total risk-based capital, Tier I capital, and Leverage ratios were 11.83%, 10.90%, and 9.14%, respectively, at June 30, 2014.

Asset Quality

Excluding the $3.7 million charge-off due to the apparent loan fraud, net charge-offs during the second quarter of 2014 would have been $56,000. Non-accrual loans increased moderately to $8.3 million from $7.5 million at March 31, 2014. The allowance for loan losses was 89% of non-accrual loans at June 30, 2014.

The acquired Rumson loans are performing as expected. Overall, we observed improving trends in loan quality with loans internally rated special mention and substandard declining during the first two quarters of the year.

Additional Information Regarding the Significant Loan Charge-off

In May of 2013, 1 st Constitution Bank (the "Bank") entered into a loan participation agreement with a lead lender and another bank to provide financing to Projuban, LLC d/b/a G3K Displays (the "Borrower"). The loan is secured by a first security interest in the Borrower's accounts receivable, inventory, equipment and fixtures, and is further secured by the continuing guarantees of the Borrower's principals.

As previously disclosed in the Company's Current Report on Form 8-K dated June 20, 2014 (the "Current Report"), the Bank, together with the lending group to the Borrower, commenced a review and investigation of the matter, which included the engagement of forensic accountants. This review and investigation revealed that the principals of the Borrower made fraudulent misrepresentations about the collateral securing the loan and the overall financial condition of the Borrower. The loan was current in payments prior to the initial discovery of the apparent fraud. As reported in the Current Report, management determined that the Borrower's financial capacity to repay the remaining balance of the loan was unlikely due to the fraud and the Borrower's cessation of operations, and that substantial doubt existed regarding future repayment of the loan. Accordingly, the Bank recorded a provision for loan losses and a corresponding charge-off of the entire balance of the loan in the amount of $3.7 million in the second quarter of 2014.

About 1 st Constitution Bancorp

1 ST Constitution Bancorp, through its primary subsidiary, 1 ST Constitution Bank, operates 19 branch banking offices in Cranbury (2), Fort Lee, Hamilton, Hightstown, Hillsborough, Hopewell, Jamesburg, Lawrenceville, Perth Amboy, Plainsboro, Rocky Hill, West Windsor, Princeton, Rumson, Fair Haven, Shrewsbury, Oceanport and Asbury Park, New Jersey.

1 ST Constitution Bancorp is traded on the Nasdaq Global Market under the trading symbol "FCCY" and can be accessed through the Internet at www.1STCONSTITUTION.com

The foregoing contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not historical facts and include expressions about management's confidence and strategies and management's expectations about new and existing programs and products, relationships, opportunities, taxation, technology and market conditions. These statements may be identified by such forward-looking terminology as "expect," "look," "believe," "anticipate," "may," "will," or similar statements or variations of such terms. Actual results may differ materially from such forward-looking statements. Factors that may cause results to differ materially from such forward-looking statements include, but are not limited to, changes in the direction of the economy in New Jersey, the direction of interest rates, effective income tax rates, loan prepayment assumptions, continued levels of loan quality and origination volume, continued relationships with major customers including sources for loans, a higher level of net loan charge-offs and delinquencies than anticipated, bank regulatory rules, regulations or policies that restrict or direct certain actions, the adoption, interpretation and implementation of new or pre-existing accounting pronouncements, a change in legal and regulatory barriers including issues related to compliance with anti-money laundering and bank secrecy act laws, as well as the effects of general economic conditions and legal and regulatory barriers and structure. 1 ST Constitution Bancorp assumes no obligation for updating any such forward-looking statements at any time, except as required by law.

1st Constitution Bancorp
Selected Consolidated Financial Data
(Unaudited)
           
           
    Three Months Ended Six Months Ended
    June 30, June 30,
($ in thousands, except per share amounts) 2014 2013 2014 2013
Income Statement Data:        
Interest income  $ 9,564  $ 7,182  $ 17,560  $ 14,654
Interest expense  1,186  1,061  2,285  2,209
Net interest income  8,378  6,121  15,275  12,445
Provision for loan losses  4,100  237  4,600  237
Net interest income after provision for loan losses  4,278  5,884  10,675  12,208
Non-interest income  1,260  1,448  2,897  3,056
Non-interest expenses  6,706  5,162  14,052  11,245
Income before income taxes  (1,168)  2,170  (480)  4,019
Income tax expense  (728)  613  (682)  1,137
Net income  $ (440)  $ 1,557  $ 202  $ 2,882
           
Per Common Share Data: (1)        
Earnings per common share - Basic  $ (0.06)  $ 0.26  $ 0.03  $ 0.48
Earnings per common share - Diluted  (0.06)  0.25  0.03  0.47
Tangible book value per common share at the period-end      9.61  10.05
Average common shares outstanding:        
Basic   7,065,458 5,992,743 6,911,972 5,944,633
Diluted   7,065,458 6,143,610 7,032,265 6,093,131
           
           
Performance Ratios / Data:        
Return on average assets -0.18% 0.77% 0.04% 0.71%
Return on average equity -2.15% 9.40% 0.52% 8.81%
Net interest income (tax-equivalent basis) (2)  $ 8,640  $ 6,383  $ 15,836  $ 12,953
Net interest margin (tax-equivalent basis) (3) 3.89% 3.42% 3.73% 3.46%
Efficiency ratio (4) 67.5% 65.9% 75.0% 70.2%
           
        June 30, December 31,
        2014 2013
Balance Sheet Data:        
Total Assets      $ 985,970  $ 742,325
Investment Securities      266,197  252,016
Loans        635,460  373,336
Loans held for sale      9,877  10,924
Allowance for loan losses      (7,418)  (7,039)
Goodwill and other intangible assets      13,615  4,889
Deposits      819,867  638,552
Shareholders' Equity      81,674  68,358
           
Asset Quality Data:        
Loans past due over 90 days and still accruing      $ --  $ --
Non-accrual loans      8,311  6,322
OREO property      1,860  2,136
Other repossessed assets      66  --
Total non-performing assets      $ 10,237  $ 8,458
           
Net charge-offs      $ (4,220)  $ (1,189)
Allowance for loan losses to total loans     1.17% 1.89%
Non-performing loans to total loans     1.31% 1.69%
Non-performing assets to total assets     1.04% 1.14%
           
Capital Ratios:        
1st Constitution Bancorp        
Tier 1 leverage ratio     9.14% 10.89%
Tier 1 capital to risk weighted assets     10.90% 18.04%
Total capital to risk weighted assets     11.83% 19.29%
1st Constitution Bank        
Tier 1 leverage ratio     8.90% 10.59%
Tier 1 capital to risk weighted assets     10.61% 17.55%
Total capital to risk weighted assets     11.54% 18.80%
         
           
(1) Includes the effect of the 5% stock dividend paid January 31, 2013.
(2)
 
The tax equivalent adjustment was computed using a Federal tax rate of 34% and was $262,000 and $262,000 for the three month period ended June 30, 2014 and 2013, respectively and was $561,000 and $508,000 for the six month period ended June 30, 2014 and 2013, respectively.
(3) Represents net interest income on a taxable equivalent basis as a percent of average interest earning assets.
(4) Represents non-interest expenses divided by the sum of net interest income on a taxable equivalent basis and non-interest income.
           
  1st Constitution Bancorp
  Average Balance Sheets with Resultant Interest and Rates
  (unaudited)
             
             
  Six months ended June 30, 2014 Six months ended June 30, 2013
(yields on a tax-equivalent basis) Average   Average Average   Average
  Balance Interest Yield Balance Interest Yield
             
Assets            
Federal Funds Sold/Short Term Investments $81,499,665 $100,708 0.25% $108,464,994 $139,342 0.26%
Investment Securities :            
Taxable 182,440,056 2,180,745 2.39% 155,253,462 1,838,797 2.39%
Tax-exempt 85,521,465 1,731,201 4.05% 65,948,918 1,566,576 4.79%
Total 267,961,521 3,911,946 2.92% 221,202,380 3,405,373 3.10%
             
Loan Portfolio:            
Construction 67,764,651 2,382,936 7.09% 42,304,486 1,295,504 6.18%
Residential real estate 42,370,454 838,609 3.99% 11,033,073 288,311 5.27%
Home Equity 21,419,673 565,208 5.32% 9,115,975 248,644 5.50%
Commercial and commercial real estate 253,561,642 7,473,017 5.94% 141,990,388 5,078,830 7.21%
Mortgage warehouse lines 100,277,323 2,332,888 4.69% 175,027,892 4,074,237 4.69%
Installment 271,935 8,198 6.08% 247,069 8,070 6.59%
All Other Loans 20,382,878 507,842 5.02% 44,819,859 623,858 2.81%
Total 506,048,556 14,108,698 5.62% 424,538,742 11,617,453 5.52%
             
Total Interest-Earning Assets  855,509,742  18,121,352 4.27%  754,206,116  15,162,168 4.05%
             
Allowance for Loan Losses (7,549,774)     (6,789,347)    
Cash and Due From Bank 16,411,917     22,409,931    
Other Assets 56,382,830     51,299,291    
Total Assets $920,754,715     $821,125,991    
             
Liabilities and Shareholders' Equity :            
Interest-Bearing Liabilities:            
Money Market and NOW Accounts $273,839,435 $447,610 0.33% $228,737,438 $401,594 0.35%
Savings Accounts 201,985,023 449,518 0.45% 205,378,084 457,986 0.45%
Certificates of Deposit 168,364,496 973,964 1.17% 141,510,623 966,354 1.38%
Other Borrowed Funds 19,146,190 243,417 2.56% 10,574,309 207,527 3.96%
Trust Preferred Securities 18,557,000 170,780 1.83% 18,557,000 175,644 1.88%
Total Interest-Bearing Liabilities 681,892,144 2,285,289 0.68% 604,757,454 2,209,105 0.74%
             
Net Interest Spread     3.59%     3.31%
             
Demand Deposits 152,619,014     140,566,574    
Other Liabilities 7,292,269     9,826,621    
Total Liabilities  841,803,427      755,150,649    
Shareholders' Equity 78,951,288     65,975,341    
Total Liabilities and Shareholders' Equity $920,754,715     $821,125,990    
             
Net Interest Margin   $15,836,063 3.73%   $12,953,063 3.46%
             
  1st Constitution Bancorp
  Reconciliation of Non-GAAP Measures (1)
  (Unaudited)
         
         
  Three Months Ended Six Months Ended
  June 30, 2014 June 30, 2013 June 30, 2014 June 30, 2013
Adjusted Net Income        
         
Net Income (Loss) (439,926) 1,557,030 201,786 2,882,348
         
Adjustments        
         
Provision for Loan losses 3,656,000 0 3,656,000 0
         
Merger-related Expenses 108,730 0 1,532,153 0
         
Income Tax Effect of Adjustments (2) (1,503,934) 0 (2,030,818) 0
         
Adjusted Net Income (Loss) 1,820,870 1,557,030 3,359,121 2,882,348
         
         
         
Adjusted Net Income (Loss) per Diluted Share        
         
Adjusted Net Income 1,820,870 1,557,030 3,359,121 2,882,348
         
Diluted Shares Outstanding (3) 7,180,127 6,143,610 7,032,265 6,093,131
         
Adjusted Net Income (Loss) per Diluted Share $0.25 $0.25 $0.48 $0.47
         
(1) The Company used the non-GAAP financial measures, adjusted net income (loss) and adjusted net income (loss) per diluted 
 share, because the Company believes that it is useful for the users of the financial information to understand the effect on
 net income of the merger related expenses incurred in the merger with Rumson Fair Haven Bank and Trust Company
 and the large provision for loan losses recorded as a result of the apparent fraud by a borrower and its principals. These
 non-GAAP financial measures improve the comparability of the current period results with the results of prior periods.
 The Company cautions that the non-GAAP financial measures should be considered in addition to, but not as a substitute for,
 the Company's GAAP results.
 
(2) Tax effected at an income tax rate of 39.94%, less the impact of non-deductible merger expenses.
 
(3) The adjustments to the reported loss for the three month period ended June 30, 2014 result in adjusted net income. 
 Accordingly, diluted shares outstanding include the dilutive share equivalents for purposes of computing adjusted net
 income per diluted share.

Robert F. Mangano President & Chief Executive Officer (609) 655-4500 Stephen J. Gilhooly Sr. Vice President & Chief Financial Officer (609) 655-4500

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading